PHS
CERE

Pekin Hardy Strauss’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Pekin Hardy Strauss’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,750
Closed -$276K – 368
2024
Q2 		$276K Hold
6,750
– – 0.04% 270
2024
Q1 		$285K Buy
+6,750
New +$284K 0.04% 276

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Pekin Hardy Strauss's CERE Position: Q3 2024 in Review

Pekin Hardy Strauss sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 6,750 shares — an estimated $276K sold.

Pekin Hardy Strauss first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $285K in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Pekin Hardy Strauss reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Pekin Hardy Strauss sold 6,750 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $276K.
  • Pekin Hardy Strauss first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Pekin Hardy Strauss's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $285K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Pekin Hardy Strauss's 13F filing for Q3 2024, filed 12 Nov 2024.